Applications of nanodiamonds in the diagnosis and treatment of neurological diseases
Source abstract
Abstract
Obtaining sufficient biocompatibility and targeting efficiency represent some of the greatest challenges for the development of diagnostic and therapeutic drugs aimed at ameliorating neurological diseases, especially neurodegenerative diseases and brain tumors. In this regard, the blood–brain barrier makes it particularly difficult to enable early diagnosis and treatment of these diseases. As a promising solution to these challenges, nanodiamonds (NDs) are an emerging class of carbon-based nanomaterials that display chemical inertness, good biocompatibility, prolonged photostability, negligible toxicity, and alternative surface functionalization. Owing to these unique physical and chemical properties, NDs have great potential for the diagnosis and treatment of neurological diseases. In this review, we explore the existing shortcomings and advantages of detection and treatment techniques for representative neurological diseases, with a focus on the use of NDs. We also discuss the potential mechanisms of NDs in the context of nano-enzymes and antiaging. Finally, we present an innovative strategy that eliminates aging cells via NDs for the potential diagnosis and treatment of neurological diseases.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Diamond and Carbon-based Materials Research · Graphene and Nanomaterials Applications · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Abbott NJ (2013) Blood-brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis 36:437–44910.1007/s10545-013-9608-0 ↗
2. Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, Athineos D, Kang TW, Lasitschka F, Andrulis M, Pascual G, Morris KJ, Khan S, Jin H, Dharmalingam G, Snijders AP, Carroll T, Capper D, Pritchard C, Inman GJ, Longerich T, Sansom OJ, Benitah SA, Zender L, Gil J (2013) A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol 15:978–99010.1038/ncb2784 ↗
3. Alawdi SH, El-Denshary ES, Safar MM, Eidi H, David MO, Abdel-Wahhab MA (2017) Neuroprotective effect of nanodiamond in Alzheimer’s disease rat model: a pivotal role for modulating NF-κB and STAT3 signaling. Mol Neurobiol 54:1906–191810.1007/s12035-016-9762-0 ↗
4. Aldape K, Zadeh G, Mansouri S, Reifenberger G, von Deimling A (2015) Glioblastoma: pathology, molecular mechanisms and markers. Acta Neuropathol 129:829–84810.1007/s00401-015-1432-1 ↗
5. Al-Tamimi BH, Jabbar HM II, Al-Tamimi (2019) Synthesis and characterization of nanocrystalline diamond from graphite flakes via a cavitation-promoted process. Heliyon 510.1016/j.heliyon.2019.e01682 ↗
6. An Y, Jiang X, Bi W, Chen H, Jin L, Zhang S, Wang C, Zhang W (2012) Sensitive electrochemical immunosensor for α-synuclein based on dual signal amplification using PAMAM dendrimer-encapsulated Au and enhanced gold nanoparticle labels. Biosens Bioelectron 32:224–23010.1016/j.bios.2011.12.017 ↗
7. Ansari MA, Scheff SW (2010) Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol 69:155–16710.1097/NEN.0b013e3181cb5af4 ↗
8. Aramesh M, Shimoni O, Ostrikov K, Prawer S, Cervenka J (2015) Surface charge effects in protein adsorption on nanodiamonds. Nanoscale 7:5726–573610.1039/C5NR00250H ↗
9. Ashek IA, Gines L, Mandal S, Song CY, Williams OA, Sarmiento MN, Cheng CL (2019) Facile Amine termination of nanodiamond particles and their surface reaction dynamics. ACS Omega 4:16715–1672310.1021/acsomega.9b00776 ↗
10. Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, Kirkland JL, van Deursen JM (2011) Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479:232–23610.1038/nature10600 ↗
11. Balasubramanian G, Lazariev A, Arumugam SR, Duan DW (2014) Nitrogen-vacancy color center in diamond-emerging nanoscale applications in bioimaging and biosensing. Curr Opin Chem Biol 20:69–7710.1016/j.cbpa.2014.04.014 ↗
12. Banks WA (2016) From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discov 15:275–29210.1038/nrd.2015.21 ↗
13. Bargiotas P, Konitsiotis S (2013) Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments. Neuropsychiatr Dis Treat 9:1605–1617
14. Barnard AS, Osawa E (2014) The impact of structural polydispersivity on the surface electrostatic potential of nanodiamond. Nanoscale 6:1188–119410.1039/C3NR05344J ↗
15. Barone FC, Marcinkiewicz C, Li J, Feng Y, Sternberg M, Lelkes PI, Rosenbaum-Halevi D, Gerstenhaber JA, Feuerstein GZ (2019) Long-term biocompatibility of fluorescent diamonds-(NV)-Z~800 nm in rats: survival, morbidity, histopathology, particle distribution and excretion studies (part IV). Int J Nanomedicine 14:1163–117510.2147/IJN.S189048 ↗
16. Basso L, Gorrini F, Cazzanelli M, Bazzanella N, Bifone A, Miotello A (2018) An all-optical single-step process for production of nanometric-sized fluorescent diamonds. Nanoscale 10:5738–574410.1039/C7NR08791H ↗
17. Betzer O, Shilo M, Opochinsky R, Barnoy E, Motiei M, Okun E, Yadid G, Popovtzer R (2017) The effect of nanoparticle size on the ability to cross the blood-brain barrier: an in vivo study. Nanomedicine (lond) 12:1533–154610.2217/nnm-2017-0022 ↗
18. Bhat R, Crowe EP, Bitto A, Moh M, Katsetos CD, Garcia FU, Johnson FB, Trojanowski JQ, Sell C, Torres C (2012) Astrocyte senescence as a component of Alzheimer’s disease. PLoS One 7:e4506910.1371/journal.pone.0045069 ↗
19. Boccardi V, Pelini L, Ercolani S, Ruggiero C, Mecocci P (2015) From cellular senescence to Alzheimer’s disease: the role of telomere shortening. Ageing Res Rev 22:1–810.1016/j.arr.2015.04.003 ↗
20. Bondar VS, Purtov KV, Puzyr AP, Baron AV (2008) Gitel’zon, II, Catalytic activity of nanodiamond particles in organic reactions. Dokl Biochem Biophys 418:11–1310.1134/S1607672908010031 ↗
21. Budge KM, Neal ML, Richardson JR, Safadi FF (2018) Glycoprotein NMB: an emerging role in neurodegenerative disease. Mol Neurobiol 55:5167–517610.1007/s12035-017-0707-z ↗
22. Chan KY, Jang MJ, Yoo BB, Greenbaum A, Ravi N, Wu WL, Sánchez-Guardado L, Lois C, Mazmanian SK, Deverman BE, Gradinaru V (2017) Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat Neurosci 20:1172–117910.1038/nn.4593 ↗
23. Chen M, Pierstorff ED, Lam R, Li SY, Huang H, Osawa E, Ho D (2009a) Nanodiamond-mediated delivery of water-insoluble therapeutics. ACS Nano 3:2016–202210.1021/nn900480m ↗
24. Chen YC, Lee DC, Hsiao CY, Chung YF, Chen HC, Thomas JP, Pong WF, Tai NH, Lin IN, Chiu IM (2009b) The effect of ultra-nanocrystalline diamond films on the proliferation and differentiation of neural stem cells. Biomaterials 30:3428–343510.1016/j.biomaterials.2009.03.058 ↗
25. Chen TM, Tian XM, Huang L, Xiao J, Yang GW (2017) Nanodiamonds as pH-switchable oxidation and reduction catalysts with enzyme-like activities for immunoassay and antioxidant applications. Nanoscale 9:15673–1568410.1039/C7NR05629J ↗
26. Chow EK, Zhang XQ, Chen M, Lam R, Robinson E, Huang H, Schaffer D, Osawa E, Goga A, Ho D (2011) Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment. Sci Transl Med 3:73ra2110.1126/scitranslmed.3001713 ↗
27. Cistaro A, Alongi P, Caobelli F, Cassalia L (2018) Radiotracers for amyloid imaging in neurodegenerative disease: state-of-the-art and novel concepts. Curr Med Chem 25:3131–314010.2174/0929867325666180117094704 ↗
28. Collins VP (1993) Amplified genes in human gliomas. Semin Cancer Biol 4:27–32
29. Delbeke D, Meyerowitz C, Lapidus RL, Maciunas RJ, Jennings MT, Moots PL, Kessler RM (1995) Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 195:47–5210.1148/radiology.195.1.7892494 ↗
30. Dexter DT, Jenner P (2013) Parkinson disease: from pathology to molecular disease mechanisms. Free Radic Biol Med 62:132–14410.1016/j.freeradbiomed.2013.01.018 ↗
31. Ding S, Khan AI, Cai X, Song Y, Lyu Z, Du D, Dutta P, Lin Y (2020) Overcoming blood-brain barrier transport: advances in nanoparticle-based drug delivery strategies. Materials Today (kidlington, England) 37:112–12510.1016/j.mattod.2020.02.001 ↗
32. Dobrovolskaia MA, Germolec DR, Weaver JL (2009) Evaluation of nanoparticle immunotoxicity. Nat Nanotechnol 4:411–41410.1038/nnano.2009.175 ↗
33. Doherty MW, Manson NB, Delaney P, Jelezko F, Wrachtrup J, Hollenberg LCL (2013) The nitrogen-vacancy colour centre in diamond. Phys Rep 528:1–4510.1016/j.physrep.2013.02.001 ↗
34. Dworak N, Wnuk M, Zebrowski J, Bartosz G, Lewinska A (2014) Genotoxic and mutagenic activity of diamond nanoparticles in human peripheral lymphocytes in vitro. Carbon 68:763–77610.1016/j.carbon.2013.11.067 ↗
35. Eitan E, Hutchison ER, Mattson MP (2014) Telomere shortening in neurological disorders: an abundance of unanswered questions. Trends Neurosci 37:256–26310.1016/j.tins.2014.02.010 ↗
36. Fink JR, Muzi M, Peck M, Krohn KA (2015) Multimodality brain tumor imaging: MR imaging, PET, and PET/MR imaging. J Nucl Med 56:1554–156110.2967/jnumed.113.131516 ↗
37. Fischer R, Maier O (2015) Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF. Oxid Med Cell Longev 2015:61081310.1155/2015/610813 ↗
38. Furtado D, Björnmalm M, Ayton S, Bush AI, Kempe K, Caruso F (2018) Overcoming the blood-brain barrier: the role of nanomaterials in treating neurological diseases Advanced materials (Deerfield Beach Fla) 3010.1002/adma.201801362 ↗
39. Gammon K (2014) Neurodegenerative disease: brain windfall. Nature 515:299–30010.1038/nj7526-299a ↗
40. Ghose AK, Viswanadhan VN, Wendoloski JJ (1999) A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery 1 A qualitative and quantitative characterization of known drug databases. J Comb Chem 1:55–6810.1021/cc9800071 ↗
41. Gorgoulis VG, Pefani DE, Pateras IS, Trougakos IP (2018) Integrating the DNA damage and protein stress responses during cancer development and treatment. J Pathol 246:12–4010.1002/path.5097 ↗
42. Gorrini F, Cazzanelli M, Bazzanella N, Edla R, Gemmi M, Cappello V, David J, Dorigoni C, Bifone A, Miotello A (2016) On the thermodynamic path enabling a room-temperature, laser-assisted graphite to nanodiamond transformation. Sci Rep 6:3524410.1038/srep35244 ↗
43. Guan B, Zou F, Zhi J (2010) Nanodiamond as the pH-responsive vehicle for an anticancer drug. Small 6:1514–151910.1002/smll.200902305 ↗
44. Guarina L, Calorio C, Gavello D, Moreva E, Traina P, Battiato A, Ditalia Tchernij S, Forneris J, Gai M, Picollo F, Olivero P, Genovese M, Carbone E, Marcantoni A, Carabelli V (2018) Nanodiamonds-induced effects on neuronal firing of mouse hippocampal microcircuits Sci Rep 8:222110.1038/s41598-018-20528-5 ↗
45. Gunawan MA, Poinsot D, Domenichini B, Dirand C, Chevalier S, Fokin AA, Schreiner PR, Hierso JC (2015) The functionalization of nanodiamonds (diamondoids) as a key parameter of their easily controlled self-assembly in micro- and nanocrystals from the vapor phase. Nanoscale 7:1956–196210.1039/C4NR04442H ↗
46. Hamilton JF, Morrison PF, Chen MY, Harvey-White J, Pernaute RS, Phillips H, Oldfield E, Bankiewicz KS (2001) Heparin coinfusion during convection-enhanced delivery (CED) increases the distribution of the glial-derived neurotrophic factor (GDNF) ligand family in rat striatum and enhances the pharmacological activity of neurturin. Exp Neurol 168:155–16110.1006/exnr.2000.7571 ↗
47. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–35610.1126/science.1072994 ↗
48. Hastie E, Samulski RJ (2015) Recombinant adeno-associated virus vectors in the treatment of rare diseases, Expert Opin Orphan. Drugs 3:675–689
49. Haziza S, Mohan N, Loe-Mie Y, Lepagnol-Bestel AM, Massou S, Adam MP, Le XL, Viard J, Plancon C, Daudin R, Koebel P, Dorard E, Rose C, Hsieh FJ, Wu CC, Potier B, Herault Y, Sala C, Corvin A, Allinquant B, Chang HC, Treussart F, Simonneau M (2017) Fluorescent nanodiamond tracking reveals intraneuronal transport abnormalities induced by brain-disease-related genetic risk factors. Nat Nanotechnol 12:322–32810.1038/nnano.2016.260 ↗
50. He N, Jin WL, Lok KH, Wang Y, Yin M, Wang ZJ (2013) Amyloid-β(1–42) oligomer accelerates senescence in adult hippocampal neural stem/progenitor cells via formylpeptide receptor 2. Cell Death Dis 4:e92410.1038/cddis.2013.437 ↗
51. Henna TK, Raphey VR, Sankar R, Ameena Shirin VK, Gangadharappa HV, Pramod K (2020) Carbon nanostructures: The drug and the delivery system for brain disorders. International Journal of Pharmaceutics 58710.1016/j.ijpharm.2020.119701 ↗
52. Heurling K, Leuzy A, Zimmer ER, Lubberink M, Nordberg A (2016) Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis. Eur J Nucl Med Mol Imaging 43:362–37310.1007/s00259-015-3208-1 ↗
53. Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, Bohr VA (2019) Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 15:565–58110.1038/s41582-019-0244-7 ↗
54. Hsu TC, Liu KK, Chang HC, Hwang E, Chao JI (2014) Labeling of neuronal differentiation and neuron cells with biocompatible fluorescent nanodiamonds. Sci Rep 4:500410.1038/srep05004 ↗
55. Huang YA, Kao CW, Liu KK, Huang HS, Chiang MH, Soo CR, Chang HC, Chiu TW, Chao JI, Hwang E (2014) The effect of fluorescent nanodiamonds on neuronal survival and morphogenesis. Sci Rep 4:691910.1038/srep06919 ↗
56. Jahangiri A, Chin AT, Flanigan PM, Chen R, Bankiewicz K, Aghi MK (2017) Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies. J Neurosurg 126:191–20010.3171/2016.1.JNS151591 ↗
57. Jain KK (2012) Nanobiotechnology-based strategies for crossing the blood–brain barrier. Nanomedicine 7:1225–123310.2217/nnm.12.86 ↗
58. Johnsen KB, Burkhart A, Melander F, Kempen PJ, Vejlebo JB, Siupka P, Nielsen MS, Andresen TL, Moos T (2017) Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma. Sci Rep 7:1039610.1038/s41598-017-11220-1 ↗
59. Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V (2010) A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 40:328–34610.3109/10408440903453074 ↗
60. Kang JH, Cho J, Ko YT (2019) Investigation on the effect of nanoparticle size on the blood-brain tumour barrier permeability by in situ perfusion via internal carotid artery in mice. J Drug Target 27:103–11010.1080/1061186X.2018.1497037 ↗
61. Karami P, SalkhiKhasraghi S, Hashemi M, Rabiei S, Shojaei A (2019) Polymer/nanodiamond composites - a comprehensive review from synthesis and fabrication to properties and applications. Adv Colloid Interface Sci 269:122–15110.1016/j.cis.2019.04.006 ↗
62. Kaushik A, Jayant RD, Tiwari S, Vashist A, Nair M (2016) Nano-biosensors to detect beta-amyloid for Alzheimer’s disease management. Biosens Bioelectron 80:273–28710.1016/j.bios.2016.01.065 ↗
63. Kaye AH, Morokoff A (2014) The continuing evolution: biology and treatment of brain tumors. Neurosurgery 61(Suppl 1):100–10410.1227/NEU.0000000000000388 ↗
64. Khalid A, Mitropoulos AN, Marelli B, Tomljenovic-Hanic S, Omenetto FG (2015) Doxorubicin loaded nanodiamond-silk spheres for fluorescence tracking and controlled drug release. Biomedical Optics Express 7:132–14710.1364/BOE.7.000132 ↗
65. Khanal D, Zhang F, Song Y, Hau H, Gautam A, Yamaguchi S, Uertz J, Mills S, Kondyurin A, Knowles JC, Georgiou G, Ramzan I, Cai W, Ng KW, Chrzanowski W (2019) Biological impact of nanodiamond particles – label free, high-resolution methods for nanotoxicity assessment. Nanotoxicology 13:1210–122610.1080/17435390.2019.1650970 ↗
66. Kheirollahi M, Mehrazin M, Kamalian N, Mehdipour P (2011) Alterations of telomere length in human brain tumors. Med Oncol 28:864–87010.1007/s12032-010-9506-3 ↗
67. Kostaras X, Cusano F, Kline GA, Roa W, Easaw J (2014) Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline. Curr Oncol 21:e493-50310.3747/co.21.1769 ↗
68. Krenning L, Feringa FM, Shaltiel IA, van den Berg J, Medema RH (2014) Transient activation of p53 in G2 phase is sufficient to induce senescence. Mol Cell 55:59–7210.1016/j.molcel.2014.05.007 ↗
69. Kritsilis M, Rizou SV, Koutsoudaki P, Evangelou K, Gorgoulis V, Papadopoulos D (2018) Ageing, cellular senescence and neurodegenerative disease. International Journal of Molecular Sciences 19:293710.3390/ijms19102937 ↗
70. Krüger A, Kataoka F, Ozawa M, Fujino T, Suzuki Y, Aleksenskii AE, Vul AY, Ōsawa E (2005) Unusually tight aggregation in detonation nanodiamond: identification and disintegration. Carbon 43:1722–173010.1016/j.carbon.2005.02.020 ↗
71. Kumar A, Ann Lin P, Xue A, Hao B, Khin Yap Y, Sankaran RM (2013) Formation of nanodiamonds at near-ambient conditions via microplasma dissociation of ethanol vapour. Nat Commun 4:261810.1038/ncomms3618 ↗
72. Kumar A, Dhawan A, Kadam A, Shinde A (2018) Autophagy and mitochondria: targets in neurodegenerative disorders. CNS Neurol Disord Drug Targets 17:696–70510.2174/1871527317666180816100203 ↗
73. Lawrence YR, Li XA, el Naqa I, Hahn CA, Marks LB, Merchant TE, Dicker AP (2010) Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 76:S20-2710.1016/j.ijrobp.2009.02.091 ↗
74. Laws ER Jr, Thapar K (1993) Brain tumors. CA Cancer J Clin 43:263–27110.3322/canjclin.43.5.263 ↗
75. Lee VM, Trojanowski JQ (2006) Mechanisms of Parkinson’s disease linked to pathological alpha-synuclein: new targets for drug discovery. Neuron 52:33–3810.1016/j.neuron.2006.09.026 ↗
76. Leitzen C, Wilhelm-Buchstab T, Schmeel LC, Garbe S, Greschus S, Mudder T, Oberste-Beulmann S, Simon B, Schild HH, Schuller H (2016) MRI during radiotherapy of glioblastoma: does MRI allow for prognostic stratification? Strahlenther Onkol 192:481–48810.1007/s00066-016-0983-y ↗
77. Li J, Zhu Y, Li W, Zhang X, Peng Y, Huang Q (2010) Nanodiamonds as intracellular transporters of chemotherapeutic drug. Biomaterials 31:8410–841810.1016/j.biomaterials.2010.07.058 ↗
78. Li M, Guan Y, Zhao A, Ren J, Qu X (2017) Using multifunctional peptide conjugated Au nanorods for monitoring β-amyloid aggregation and chemo-photothermal treatment of Alzheimer’s disease. Theranostics 7:2996–300610.7150/thno.18459 ↗
79. Lieberman NAP, Vitanza NA, Crane CA (2018) Immunotherapy for brain tumors: understanding early successes and limitations. Expert Rev Neurother 18:251–25910.1080/14737175.2018.1425617 ↗
80. Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787–79510.1038/nature05292 ↗
81. Lin YC, Wu KT, Lin ZR, Perevedentseva E, Karmenyan A, Lin MD, Cheng CL (2016) Nanodiamond for biolabelling and toxicity evaluation in the zebrafish embryo in vivo. J Biophotonics 9:827–83610.1002/jbio.201500304 ↗
82. Lipton SA (2004) Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer’s disease and other neurologic disorders. J Alzheimers Dis 6:S61-7410.3233/JAD-2004-6S610 ↗
83. Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9:106–11810.1038/nrneurol.2012.263 ↗
84. Loaiza N, Demaria M (1865) Cellular senescence and tumor promotion: is aging the key? Biochim Biophys Acta 2016:155–167
85. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW, The, (2016) World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131(2016):803–82010.1007/s00401-016-1545-1 ↗
86. Madabhushi R, Pan L, Tsai LH (2014) DNA damage and its links to neurodegeneration. Neuron 83:266–28210.1016/j.neuron.2014.06.034 ↗
87. Man HB, Ho D (2013) Nanodiamonds as platforms for biology and medicine. J Lab Autom 18:12–1810.1177/2211068212456198 ↗
88. Mangir N, Roman S, MacNeil S (2019) Improving the biocompatibility of biomaterial constructs and constructs delivering cells for the pelvic floor. Curr Opin Urol 29:419–42510.1097/MOU.0000000000000621 ↗
89. Marcon L, Riquet F, Vicogne D, Szunerits S, Bodart J-F, Boukherroub R (2010) Cellular and in vivo toxicity of functionalized nanodiamond in Xenopus embryos. Journal of Materials Chemistry 20:8064–806910.1039/c0jm01570a ↗
90. Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ (2010) Decreased clearance of CNS beta-amyloid in Alzheimer’s disease. Science 330:177410.1126/science.1197623 ↗
91. Maziukiewicz D, Grzeskowiak BF, Coy E, Jurga S, Mrowczynski R (2019) NDs@PDA@ICG conjugates for photothermal therapy of glioblastoma multiforme. Biomimetics (Basel) 4:310.3390/biomimetics4010003 ↗
92. McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains. Neurology 38:1285–129110.1212/WNL.38.8.1285 ↗
93. Merson TD, Castelletto S, Aharonovich I, Turbic A, Kilpatrick TJ, Turnley AM (2013) Nanodiamonds with silicon vacancy defects for nontoxic photostable fluorescent labeling of neural precursor cells. Opt Lett 38:4170–417310.1364/OL.38.004170 ↗
94. Miccoli B, Braeken D, Li YE (2018) Brain-on-a-chip devices for drug screening and disease modeling applications. Curr Pharm Des 24:5419–543610.2174/1381612825666190220161254 ↗
95. Mochalin VN, Shenderova O, Ho D, Gogotsi Y (2011) The properties and applications of nanodiamonds. Nat Nanotechnol 7:11–2310.1038/nnano.2011.209 ↗
96. Moodley KK, Chan D (2014) The hippocampus in neurodegenerative disease. Front Neurol Neurosci 34:95–10810.1159/000356430 ↗
97. Moore L, Yang J, Lan TT, Osawa E, Lee DK, Johnson WD, Xi J, Chow EK, Ho D (2016) Biocompatibility assessment of detonation nanodiamond in non-human primates and rats using histological, hematologic, and urine analysis. ACS Nano 10:7385–740010.1021/acsnano.6b00839 ↗
98. Morales-Zavala F, Casanova-Morales N, Gonzalez RB, Chandia-Cristi A, Estrada LD, Alvizu I, Waselowski V, Guzman F, Guerrero S, Oyarzun-Olave M, Rebolledo C, Rodriguez E, Armijo J, Bhuyan H, Favre M, Alvarez AR, Kogan MJ, Maze JR (2018) Functionalization of stable fluorescent nanodiamonds towards reliable detection of biomarkers for Alzheimer’s disease. J Nanobiotechnology 16:6010.1186/s12951-018-0385-7 ↗
99. Moscariello P, Raabe M, Liu W, Bernhardt S, Qi H, Kaiser U, Wu Y, Weil T, Luhmann HJ, Hedrich J (2019) Unraveling in vivo brain transport of protein-coated fluorescent nanodiamonds. Small 15:e190299210.1002/smll.201902992 ↗
100. Mytych J, Lewinska A, Bielak-Zmijewska A, Grabowska W, Zebrowski J, Wnuk M (2014) Nanodiamond-mediated impairment of nucleolar activity is accompanied by oxidative stress and DNMT2 upregulation in human cervical carcinoma cells. Chem Biol Interact 220:51–6310.1016/j.cbi.2014.06.004 ↗